About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

WITHDRAWNNANCT06707038

Improving Access to Renal Transplantation for Underserved Black Communities

The goal of this clinical trial is to learn whether the African American Transplant Access Program can be successfully replicated at another large kidney transplant program. The main questions it aims...

Lead sponsor: Northwestern University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Northwestern University

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Tampa General Hospital

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•self-identify as Black or African American;
•18 to 75 years of age
•have an eGFR \< 20 or End Stage Renal Disease Diagnosis;
•screen positive for AATAP via the screener (for poor health literacy or poor medical adherence or psychosocial concerns);
•medically eligible to begin transplant evaluation process determined by transplant team

Exclusion Criteria

•other racial groups
•participants who have previously received a transplant;
•pregnant women;
•participants who screen negative on the screener;
•children less than 18 years old

Related studies

RECRUITINGPhase 2

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children

NCT05753930 · Kidney Transplantation in Highly Sensitized Patients

RECRUITINGPhase 2

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

NCT06059664 · Kidney Transplant; Complications

RECRUITINGPhase 3

Shingrix in Renal Transplant Recipients

NCT04128189 · Kidney Transplant Recipient Response to Shingrix Vaccine, Kidney Failure, and more

RECRUITINGPhase 3

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

NCT05325008 · BK Viremia, Kidney Transplant Infection, and more

RECRUITINGPhase 2/3

A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

NCT07412470 · Kidney Transplant Rejection

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 9, 2025Terms

Trial snapshot

StatusWITHDRAWN

PhaseNA

Enrollment—

Start dateApr 2025

Last updatedMay 9, 2025

Condition

Kidney Transplant ESRD (End Stage Renal Disease)

Locations shown

Tampa General Hospital

Tampa, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 9, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions